GREENLIGHT BIOSCIENCES HOLDI (GRNA)       1.11  -0.01 (-0.89%)

Company Profile

GreenLight Biosciences Holdings PBC operates as a biotechnology company, which makes ribonucleic acid (RNA) products for human therapies and agriculture. The company is headquartered in Medford, Massachusetts. The company went IPO on 2021-01-14. The firm is focused on Ribonucleic acid (RNA) research, design, and manufacturing for human, animal, and plant health. The firm has developed technology to create high-performing, natural ribonucleic acid (RNA) products to address global sustainability challenges and promote healthier plants, foods, and people. The firm is engaged in the cell-free biomanufacturing platform. This platform enables the making of complex biological molecules nucleic acids, peptides, carbohydrates, and many others which allows manufacturing products at a lower cost than traditional methods using fermentation. The platform is used to develop and commercialize products. The firm's pipeline for plant and animal health includes Colorado potato beetle, Botrytis cinerea, Varroa mites, Fungicides, Grapevine powdery mildew, Fusarium Head Blight (FHB), Lepidoptera, and Powdery mildew.

Company Info

GREENLIGHT BIOSCIENCES HOLDI

200 Boston Avenue, Suite 3100

Medford MASSACHUSETTS

P: 16176168188.0

Employees: 312

Website: https://greenlightbiosciences.com/